Scarica l'app Stockscreener
1.975
5.85%
0.095
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
Fed Watch: Can Caribou Biosciences Inc expand its profit marginsMarket Activity Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Is Caribou Biosciences Inc a cyclical or defensive stockWeekly Trade Recap & High Conviction Buy Zone Picks - baoquankhu1.vn
How does Caribou Biosciences Inc compare to its peersPortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn
Caribou Biosciences stock faces pressure amid biotech volatility and pipeline updates - AD HOC NEWS
Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results - MSN
Market Catalysts: Is Caribou Biosciences Inc benefiting from interest rate changesWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
CRBU Earnings History & Surprises | EPS & Revenue Results | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill
Trading Action: How does Caribou Biosciences Inc compare to its peersInsider Buying & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Signal Recap: Is Caribou Biosciences Inc stock good for income investors2026 Macro Moves & Precise Swing Trade Alerts - baoquankhu1.vn
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value - Seeking Alpha
Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink Conference - MarketBeat
CRBU Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Analysts Are Bullish on Top Healthcare Stocks: Caribou Biosciences (CRBU), Oncology Institute (TOI) - The Globe and Mail
Drug Pricing Reforms Threaten Caribou Biosciences’ Future Margins and Market Access - The Globe and Mail
Caribou Biosciences: Advancing Allogeneic Cell Therapy Pipeline and Pivotal Trial Plans Support High-Risk Buy Rating - TipRanks
Truist reiterates Buy on Caribou Biosciences stock, $7 target - Investing.com Australia
Truist reiterates Buy on Caribou Biosciences stock, $7 target By Investing.com - Investing.com UK
Caribou Biosciences, Inc. (CRBU) reports Q4 loss, tops revenue estimates - MSN
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network
Caribou Biosciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Caribou Biosciences (NASDAQ:CRBU) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Caribou Biosciences announces Q4 and FY2025 financial results - Traders Union
Caribou Biosciences Q4 licensing revenue rises, net loss narrows - TradingView
Insights into Caribou Biosciences Q4 Earnings - Benzinga
Caribou Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
CRBU: Strong clinical progress and improved financials position the pipeline for pivotal trials - TradingView
Caribou Biosciences (Nasdaq: CRBU) details 2025 loss and CAR-T trial plans - Stock Titan
BRIEF-Caribou Biosciences Q4 Licensing And Collaboration Revenue USD 3.941 Million - TradingView
Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments - Stocktwits
CRBU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Caribou Biosciences (CRBU) to Release Earnings on Monday - MarketBeat
Insider Sell: Timothy Kelly Sells Shares of Caribou Biosciences Inc (CRBU) - GuruFocus
Caribou Biosciences Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Caribou Biosciences (CRBU) CTO sells 6,228 shares in open-market trade - Stock Titan
7 Top Gene-Editing Stocks to Buy - US News Money
Caribou Biosciences (NASDAQ: CRBU) notice to sell 6,938 vested shares - Stock Titan
Caribou Biosciences (NASDAQ: CRBU) files Rule 144 to sell 6,938 shares - Stock Titan
Timothy Kelly sells 3,147 CRBU shares; proposed sale of 6,228 restricted shares (CRBU) - Stock Titan
Decliners Report: Is Roivant Sciences Ltd stock undervalued right nowJuly 2025 Update & Daily Growth Stock Tips - baoquankhu1.vn
Caribou Biosciences (NASDAQ:CRBU) Insider Ruhi Ahmad Khan Sells 6,938 Shares - MarketBeat
Caribou Biosciences CLO sold $13,598 in CRBU stock - Investing.com Australia
Caribou Biosciences CLO sold $13,598 in CRBU stock By Investing.com - Investing.com Canada
Caribou Biosciences CTO Kelly sells $6.1k in shares By Investing.com - Investing.com Canada
Khan, Caribou Biosciences CBO, sells $13598 in stock - Investing.com Australia
Khan, Caribou Biosciences CBO, sells $13598 in stock By Investing.com - Investing.com Canada
Caribou Biosciences (CRBU) CBO awarded stock options, sells shares for tax - Stock Titan
[Form 4] Caribou Biosciences, Inc. Insider Trading Activity - Stock Titan
Growth Value: Is Caribou Biosciences Inc benefiting from interest rate changesMarket Risk Report & Intraday High Probability Alerts - baoquankhu1.vn
Earnings Risk: Is Magyar Bancorp Inc stock a falling knife or bargain buyJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - baoquankhu1.vn
Caribou Biosciences Details Pivotal-Ready Vispa-cel Plan, Flags Need for More Capital at Citi Summit - MarketBeat
Should you avoid Caribou Biosciences Inc. stock right now2025 Earnings Impact & Weekly Watchlist for Consistent Profits - mfd.ru
Volume Report: Is NCIQ stock forming a cup and handleSwing Trade & Weekly High Potential Alerts - baoquankhu1.vn
Short Squeeze: How does Caribou Biosciences Inc compare to its peersInflation Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):